Sartorius Stedim Biotech S.A. (FRA:56S1)

Germany · Delayed Price · Currency is EUR

213.90

-1.50 (-0.70%)

Last updated: Dec 5, 2025, 8:03 AM CET

Revenue by Geography

Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	2013 - 2020
Period Ending	Jun '25 Jun 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	2013 - 2020
EMEA Revenue	1.21B	1.16B	Log In	Log In	Log In	Upgrade
Americas Revenue	1.03B	982.00M	Log In	Log In	Log In	Upgrade
Asia Pacific Revenue	656.10M	639.00M	Log In	Log In	Log In	Upgrade

Revenue

Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	2013 - 2020
Period Ending	Jun '25 Jun 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	2013 - 2020
Recurring Revenue	2.41B	2.22B	Log In	Log In	Log In	Upgrade
Non-Recurring Revenue	485.20M	557.10M	Log In	Log In	Log In	Upgrade

Key Performance Indicators

Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	2013 - 2020
Period Ending	Jun '25 Jun 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	2013 - 2020
Underlying EBITDA	853.60M	779.00M	Log In	Log In	Log In	Upgrade
Total Order Intake	-	2.78B	Log In	Log In	Log In	Upgrade